AstraZeneca says Mylan, Kindeva infringe another Symbicort patent

28-04-2022

Alex Baldwin

AstraZeneca says Mylan, Kindeva infringe another Symbicort patent

Mats Wiklund / Shutterstock.com

AstraZeneca filed a patent infringement lawsuit against Mylan Pharmaceuticals and Kindeva Drug Delivery on Tuesday, claiming that their generic asthma Symbicort (budesonide/formoterol) infringes a brand-new patent that was issued the same day.


AstraZeneca, Mylan Pharmaceuticals, Kindeva Drug Delivery, Symbicort, patent infringement, ANDA, generics, asthma inhaler

LSIPR